Abstract
SARS-CoV-2 vaccines: fast track versus efficacy
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/s2666-5247(21)00034-3
Journal: The Lancet Microbe | Publication Date: Feb 9, 2021 |
Citations: 19 | License type: cc-by-nc-nd |
SARS-CoV-2 vaccines: fast track versus efficacy
Join us for a 30 min session where you can share your feedback and ask us any queries you have